Cite
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
MLA
Oldroyd, Alexander G. S., et al. “A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies.” Rheumatology (Oxford, England), vol. 60, no. 6, June 2021, pp. 2615–28. EBSCOhost, https://doi.org/10.1093/rheumatology/keab166.
APA
Oldroyd, A. G. S., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., George, M. D., Gordon, P., Kolstad, K., Kurtzman, D. J. B., Machado, P. M., McHugh, N. J., Postolova, A., Selva-O’Callaghan, A., Schmidt, J., Tansley, S., Vleugels, R. A., Werth, V. P., & Aggarwal, R. (2021). A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford, England), 60(6), 2615–2628. https://doi.org/10.1093/rheumatology/keab166
Chicago
Oldroyd, Alexander G S, Andrew B Allard, Jeffrey P Callen, Hector Chinoy, Lorinda Chung, David Fiorentino, Michael D George, et al. 2021. “A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies.” Rheumatology (Oxford, England) 60 (6): 2615–28. doi:10.1093/rheumatology/keab166.